Home » Stocks » PAHC

Phibro Animal Health Corporation (PAHC)

Stock Price: $26.81 USD -0.11 (-0.41%)
Updated May 11, 2021 10:19 AM EDT - Market open
Market Cap 1.10B
Revenue (ttm) 798.96M
Net Income (ttm) 42.91M
Shares Out 40.48M
EPS (ttm) 1.06
PE Ratio 25.32
Forward PE 19.65
Dividend $0.48
Dividend Yield 1.79%
Trading Day May 11
Last Price $26.81
Previous Close $26.92
Change ($) -0.11
Change (%) -0.41%
Day's Open 26.47
Day's Range 26.47 - 26.97
Day's Volume 5,560
52-Week Range 16.08 - 27.76

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Phibro's (PAHC) fiscal third-quarter revenues improved year over year on growth in Performance Products and Mineral Nutrition segments.

4 days ago - Zacks Investment Research

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) today announced financial results for its third quarter and year-to-date period ended March 31, 2021. Highlights for the Ma...

4 days ago - Business Wire

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class...

1 week ago - Business Wire

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) announced today that on April 22, 2021, the Company entered into an amended and restated credit agreement. Under the amende...

2 weeks ago - Business Wire

Investors continue to be optimistic about Phibro (PAHC), owing to its potential in Performance Products and consistent high demand for its nutritional specialty products.

4 weeks ago - Zacks Investment Research

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its third quarter financial results on Thursday, May 6, 2021, after the market closes. Phibro managemen...

1 month ago - Business Wire

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) announced today it will participate in the Bank of America Securities 2021 Virtual Healthcare Conference. Chairman, Preside...

1 month ago - Business Wire

PAHC vs. SRDX: Which Stock Is the Better Value Option?

Other stocks mentioned: SRDX
1 month ago - Zacks Investment Research

In anticipation of the Fed's big announcement on interest rates and inflation, Q.ai's Artificial Intelligence has brought you today's top buys.

Other stocks mentioned: MWA, PBH, PG, STRA
1 month ago - Forbes

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

2 months ago - Zacks Investment Research

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) announced it will participate in the Barclays Virtual Global Healthcare Conference. Chairman, President and Chief Executive...

3 months ago - Business Wire

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) announced it will participate in the Bank of America Merrill Lynch 2021 Virtual Animal Health Summit. Chairman, President a...

3 months ago - Business Wire

PAHC vs. RMD: Which Stock Is the Better Value Option?

Other stocks mentioned: RMD
3 months ago - Zacks Investment Research

Phibro's (PAHC) second-quarter revenue declined 3.7% year over year to $206.1 million and gross profit improved 33%.

3 months ago - Zacks Investment Research

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) today announced financial results for its second quarter ended December 31, 2020. Highlights for the December 31, 2020 quar...

3 months ago - Business Wire

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class...

3 months ago - Business Wire

PAHC vs. SRDX: Which Stock Is the Better Value Option?

Other stocks mentioned: SRDX
3 months ago - Zacks Investment Research

Phirbo's (PAHC) net vaccine sales remain robust on higher international demand for poultry vaccines.

3 months ago - Zacks Investment Research

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its second quarter financial results on Wednesday, February 3, 2021, after the market closes. Phibro ma...

4 months ago - Business Wire

Phibro was hit by the COVID-19 pandemic in FY 2020, but did show an acceptable net income and free cash flow. It shouldn't be too easy for Phibro to beat its 2020 results, and the Q1 results and Q2 guid...

4 months ago - Seeking Alpha

These are the pharmaceutical stocks with the best value, fastest growth, and most momentum for Q1 2021.

Other stocks mentioned: AMPH, AMRX, BIIB, HZNP, SUPN
5 months ago - Investopedia

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

5 months ago - Zacks Investment Research

Lower sales of Phibro's (PAHC) Performance Products arm's copper-based products raise concerns.

5 months ago - Zacks Investment Research

Phibro Animal Health Corporation (PAHC) CEO Jack Bendheim on Q1 2021 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Phibro's (PAHC) core Animal Health segment, along with strength in Nutritional Specialties and Vaccines, boosted Q1 performance despite pandemic-led business disruptions.

6 months ago - Zacks Investment Research

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its first quarter ended September 30, 2020. Highlights for the September 30, 2020...

6 months ago - Business Wire

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class...

6 months ago - Business Wire

PAHC vs. RMD: Which Stock Is the Better Value Option?

Other stocks mentioned: RMD
6 months ago - Zacks Investment Research

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) announced today it will participate in the 29th Annual Credit Suisse Virtual Healthcare Conference. Chairman, President and...

6 months ago - Business Wire

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its first quarter financial results on Wednesday, November 4, 2020, after the market closes. Phibro man...

7 months ago - Business Wire

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

7 months ago - Zacks Investment Research

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (the “Company” or “Phibro”) today announced that Richard Johnson, Phibro’s Chief Financial Officer, has informed the Company that he will...

7 months ago - Business Wire

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) announced today it will participate in the Morgan Stanley Virtual Annual Global Healthcare Conference.

8 months ago - Business Wire

Phirbo (PAHC) catered industries face issues like lack of processing availability and sudden drop in demand.

8 months ago - Zacks Investment Research

Phibro Animal Health Corporation (PAHC) CEO Jack Bendheim on Q4 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Phibro's (PAHC) core Animal Health segment was aided by the Osprey Biotechnics acquisition despite a dismal overall performance in Q4 due to pandemic-led business disruptions.

8 months ago - Zacks Investment Research

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its fourth quarter and fiscal year ended June 30, 2020.

8 months ago - Business Wire

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its fourth quarter and fiscal year 2020 financial results on Wednesday, August 26, 2020, after the mark...

9 months ago - Business Wire

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class...

9 months ago - Business Wire

TEANECK, N.J.--(BUSINESS WIRE)--(NASDAQ:PAHC) Today, the Food and Drug Administration (FDA) provided notice of Federal Register publication of its intention to take a number of actions related to its on...

9 months ago - Business Wire

Spending on pet health continues to climb. Investors should consider buying PetMed Express, Phibro Animal Health, and Merck & Co.

Other stocks mentioned: MRK, PETS
11 months ago - The Motley Fool

Phibro (PAHC) witnessed revenue uptick in its core Animal Health segment in Q3 despite the coronavirus-led business disruptions in the animal production industry.

11 months ago - Zacks Investment Research

Phibro Animal Health Corporation (PAHC) CEO Jack Bendheim on Q3 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...

1 year ago - Zacks Investment Research

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

1 year ago - Zacks Investment Research

PRGO vs. PAHC: Which Stock Is the Better Value Option?

Other stocks mentioned: PRGO
1 year ago - Zacks Investment Research

The company raised guidance, and also raised hopes about its vaccine candidate for African swine fever.

1 year ago - The Motley Fool

Phibro Animal Health Corporation (PAHC) CEO Jack Bendheim on Q2 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Phibro (PAHC) witnessed revenue decline in two of its core segments and contraction in operating margin in Q2.

1 year ago - Zacks Investment Research

PRGO vs. PAHC: Which Stock Is the Better Value Option?

Other stocks mentioned: PRGO
1 year ago - Zacks Investment Research

About PAHC

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industr... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Apr 11, 2014
CEO
Jack Bendheim
Employees
1,700
Stock Exchange
NASDAQ
Ticker Symbol
PAHC
Full Company Profile

Financial Performance

In 2020, PAHC's revenue was $800.35 million, a decrease of -3.34% compared to the previous year's $828.00 million. Earnings were $33.55 million, a decrease of -38.68%.

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for PAHC stock is "Hold." The 12-month stock price forecast is 20.50, which is a decrease of -23.54% from the latest price.

Price Target
$20.50
(-23.54% downside)
Analyst Consensus: Hold